HDAC Inhibition Induces Transient Phenotypic Inertia in Dormant OCCC Spheroids by Derepression of Cell Cycle Genes
Cells · 2026
DOI: 10.3390/cells15080673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Sylvia Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mary & John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Centre, London, ON N6A 4L6, Canada. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Spheroids, Cellular, Ovarian Neoplasms, Cell Cycle. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: London Health Sciences Foundation.
Abstract (Originalsprache)
Multicellular cancer cell aggregates, termed spheroids, are anoikis-resistant, avascular, heterogeneous structures responsible for transcoelomic metastasis of ovarian clear cell carcinoma (OCCC). OCCC is a rare subtype of ovarian cancer with high ARID1A gene mutation rates, resulting in genome-wide changes to H3K27Ac levels and histone deacetylase (HDAC) function. Our study investigated the utility of HDAC inhibitor (HDACi) treatment and H3K27Ac dynamics in OCCC spheroids. By comparing KOC-7c and 105C OCCC cell lines, which have opposing abilities to proliferate as spheroids, we revealed that KOC-7c and 105C spheroids differentially regulated H3K27Ac levels, which correlated with the sensitivity of KOC-7c and the resistance of 105C spheroids to H3K27Ac-altering HDACi treatment. RNA-seq of Entinostat-treated versus vehicle-treated spheroids resulted in a dramatic change in the 105C spheroid transcriptome such that it more closely resembled the proliferative KOC-7c transcriptome over the short term. Comparative pathway analysis identified preferential de-repression of a G2/M checkpoint gene program in 105C spheroids upon Entinostat treatment when compared directly to the KOC-7c spheroids. Our results suggest that the utility of HDACi in OCCC is highly context-dependent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mary & John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Centre, London, ON N6A 4L6, Canada.
- Department of Biochemistry, Western University, London, ON N6A 3K7, Canada.
- London Health Sciences Centre Research Institute, London, ON N6A 4L6, Canada.
- Department of Oncology, Western University, London, ON N6A 3K7, Canada.
- Department of Anatomy & Cell Biology, Western University, London, ON N6A 3K7, Canada.
- Department of Obstetrics & Gynaecology, Western University, London, ON N6A 3K7, Canada.
ORCID-Profile: Sylvia Cheng, Bart Kolendowski, Trevor G Shepherd, Gabriel E DiMattia
Förderung
- London Health Sciences Foundation
Zitieren
APA
Cheng, S., Kolendowski, B., Ramos-Valdes, Y., Shepherd, T. G., & DiMattia, G. E. (2026). HDAC Inhibition Induces Transient Phenotypic Inertia in Dormant OCCC Spheroids by Derepression of Cell Cycle Genes. Cells. https://doi.org/10.3390/cells15080673
Vancouver
Cheng S, Kolendowski B, Ramos-Valdes Y, Shepherd TG, DiMattia GE. HDAC Inhibition Induces Transient Phenotypic Inertia in Dormant OCCC Spheroids by Derepression of Cell Cycle Genes. Cells. 2026. doi:10.3390/cells15080673
BibTeX
@article{Cheng2026,
author = {Cheng, Sylvia and Kolendowski, Bart and Ramos-Valdes, Yudith and Shepherd, Trevor G and DiMattia, Gabriel E},
title = {HDAC Inhibition Induces Transient Phenotypic Inertia in Dormant OCCC Spheroids by Derepression of Cell Cycle Genes},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15080673}
}
EUVIMED